Bulevirtide and emerging drugs for the treatment of hepatitis D

By sjmartinez • October 19, 2023

Xu HY, Yang JO, Chen PH, Han SB. Bulevirtide and emerging drugs for the treatment of hepatitis D. Expert Opin Biol Ther. 2023 Oct 18. doi: 10.1080/14712598.2023.2273260. Epub ahead of print. PMID: 37853604.

Tags: Digestive Diseases, Fellow, General Internal Medicine, Publications, Resident

Investigating shared genetic architecture between inflammatory bowel diseases and primary biliary cholangitis

Huang W, Jiang R, Li S, Zeng R, Li Y, Zhang Y, Tong S, Lyu Y, Wang J, Lian Q, Leung FW, Luo R, Sha[...]

Lower FIB-4 threshold in patients with diabetes improves diagnostic accuracy of the test in a Hispanic population

Singh J, Ibrahim B, Jackson NJ, Khalil H, Valenzuela J, Yanny B, Saab S. Lower FIB-4 threshold in patients with diabetes improves diagnostic accuracy of[...]

Role of the prefrontal cortical protease TACE/ADAM17 in neurobehavioral responses to chronic stress during adolescence

Sharafeddin F, Sierra J, Ghaly M, Simon TB, Ontiveros-Ángel P, Edelbach B, Febo M, Labus J, Figueroa JD. Role of the prefrontal cortical protease TACE/ADAM17[...]